Heart Valve Disease

How to evaluate a patient with valve disease The Heart Team The Valve Center.- Aortic Valve Stenosis Epidemiology Clinical presentation Diagnosis Echo Cath MRI Other imaging modalities Treatment. What do the guidelines say Future directions.- Aortic Regurgitatio Epidemiology Clinical presentation Diagnosis Echo Cath MRI Other imaging modalities Treatment. What do the guidelines say Future directions.- Mitral Stenosis Epidemiology Clinical presentation Diagnosis Echo Cath MRI Other imaging modalities Treatment. What do the guidelines say Future directions.- Mitral regurgitation Epidemiology Clinical presentation Diagnosis Echo Cath MRI Other imaging modalities Treatment. What do the guidelines say Future directions .- Tricuspid Stenosis Epidemiology Clinical presentation Diagnosis Echo Cath MRI Other imaging modalities Treatment. What do the guidelines say Future directions.- Tricuspid regurgitation Epidemiology Clinical presentation Diagnosis Echo Cath MRI Other imaging modalities Treatment. What do the guidelines say Future directions .- Pulmonar stenosis Epidemiology Clinical presentation Diagnosis Echo Cath MRI Other imaging modalities Treatment. What do the guidelines say Future directions .- Pulmonary Regurgitation Epidemiology Clinical presentation Diagnosis Echo Cath MRI Other imaging modalities Treatment. What do the guidelines say Future directions .- Endocarditis Clinical presentation Diagnosis Echo Cath MRI Other imaging modalities Treatment. What do the guidelines say .- Imaging inside the cath lab. TAVI Before the intervention. What to do? During the intervention. How to assess complications. How to follow .- Mitral valve interventions for Regurgitation Before the intervention. What to do? During the intervention. How to assess complications. How to follow Future directions.- Mitral valve interventions for Stenosis Before the intervention. What to do? During the intervention. How to assess complications. How to follow .- tricuspid valve interventions

José Luis Zamorano is Professor of Medicine at the University Alcala in Madrid and Director of the Cardiovascular department at the University Hospital Ramon y Cajal, Madrid. His key research interests include ischaemic heart disease, cardiovascular risk factors and imaging modalities. Professor Zamorano is Past President of the European Association of Echocardiography (EAE) and Past President of the Working Group on Non-invasive Diagnostic Imaging of the Spanish Society of Cardiology. Currently Vice president of the European Society of Cardiology. He served on numerous Editorial Boards, including the European Journal of Echocardiography, the American Society of Echocardiography and the European Heart Journal. He has authored over 400 articles for peer-reviewed journals. He gained his MD from the University Complutense in 1987.Patricio Lanzelloti is a pioneer in the field of valvular heart disease. He has published several papers related to the main topic of the present book and is part of the guidelines writing group on valvular heart disease. He has already co-edited several books including the secondary mitral regurgitation with Khalil Fattouch.


Luc Pierard is honorary Professor of Medicine at the University of Liège, Belgium and was Head of the Department of Cardiology of the University Hospital Sart Tilman in Liège from 2002 to 2017. He was the first to demonstrate the utility of dobutamine stress echocardiography for identifying myocardial viability and ischemia and to use exercise echocardiography in valvular heart diseases. He was President of the Belgian Society of Cardiology and had several positions in the European Society of Cardiology: he chaired the Working Group on Echocardiography and is currently chairperson of the ESC Council in Valvular Heart Disease. He is Editor-in-Chief of Acta Cardiologica and Senior Associate Editor of the EHJ Cardiovascular Imaging. He has published more than 400 peer-reviewed articles (many on valvular heart